0001373604-24-000028.txt : 20240516
0001373604-24-000028.hdr.sgml : 20240516
20240516085826
ACCESSION NUMBER: 0001373604-24-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240514
FILED AS OF DATE: 20240516
DATE AS OF CHANGE: 20240516
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leonard Braden Michael
CENTRAL INDEX KEY: 0001373603
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 24953732
MAIL ADDRESS:
STREET 1: 156 S. FIRST STREET
CITY: ZIONSVILLE
STATE: IN
ZIP: 46077
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 18575 JAMBOREE ROAD
STREET 2: SUITE 275-S
CITY: IRVINE
STATE: CA
ZIP: 92612
4
1
form4.xml
X0508
4
2024-05-14
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001373603
Leonard Braden Michael
65 E CEDAR - SUITE 2
ZIONSVILLE
IN
46077
true
false
Common Stock
2024-05-14
4
P
0
79281
1.56
A
2337194
I
Holding of BML Investment Partners, L.P.
Common Stock
2024-05-14
4
P
0
335000
1.54
A
2672194
I
Holding of BML Investment Partners, L.P.
Common Stock
1020769
D
BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein.
Purchased in multiple transactions with a weighted average price of $1.56. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
Purchased in multiple transactions with a weighted average price of $1.54. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range.
/s/ Braden Michael Leonard
2024-05-16